Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ARDT Stock Forecast 2026-2027
$8.83
Current Price
$1.24B
Market Cap
Buy 7
Hold 4
Sell 1
Wall St Analyst Ratings
Distance to ARDT Price Targets
+58.6%
To High Target of $14.00
+47.2%
To Median Target of $13.00
+13.3%
To Low Target of $10.00
ARDT Price Momentum
-4.7%
1 Week Change
-12.7%
1 Month Change
-35.5%
1 Year Change
0.0%
Year-to-Date Change
-43.0%
From 52W High of $15.48
+14.5%
From 52W Low of $7.71
📊 TOP ANALYST CALLS
Did ARDT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Ardent Health is one of their latest high-conviction picks.
Latest ARDT Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, ARDT has a bullish consensus with a median price target of $13.00 (ranging from $10.00 to $14.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $8.83, the median forecast implies a 47.2% upside. This outlook is supported by 7 Buy, 4 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ARDT Analyst Ratings
7
Buy
4
Hold
1
Sell
ARDT Price Target Range
Low
$10.00
Average
$13.00
High
$14.00
Current: $8.83
Latest ARDT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ARDT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 7, 2026 | UBS | A.J. Rice | Buy | Maintains | $13.50 |
| Mar 10, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| Mar 6, 2026 | Leerink Partners | Outperform | Maintains | $N/A | |
| Jan 20, 2026 | JP Morgan | Neutral | Maintains | $N/A | |
| Dec 18, 2025 | UBS | Buy | Maintains | $N/A | |
| Dec 18, 2025 | Mizuho | Outperform | Maintains | $N/A | |
| Nov 24, 2025 | JP Morgan | Neutral | Maintains | $N/A | |
| Nov 18, 2025 | Mizuho | Outperform | Maintains | $N/A | |
| Nov 18, 2025 | Guggenheim | Buy | Maintains | $N/A | |
| Nov 17, 2025 | Keybanc | Sector Weight | Downgrade | $N/A | |
| Nov 14, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Nov 14, 2025 | Truist Securities | Buy | Maintains | $N/A | |
| Nov 14, 2025 | Stephens & Co. | Overweight | Maintains | $N/A | |
| Nov 14, 2025 | Morgan Stanley | Equal-Weight | Downgrade | $N/A | |
| Nov 13, 2025 | B of A Securities | Underperform | Maintains | $N/A | |
| Oct 14, 2025 | Goldman Sachs | Neutral | Initiates | $N/A | |
| Sep 10, 2025 | UBS | Buy | Initiates | $N/A | |
| Aug 11, 2025 | JP Morgan | Neutral | Maintains | $N/A | |
| Aug 7, 2025 | Keybanc | Overweight | Maintains | $N/A | |
| Jul 16, 2025 | B of A Securities | Underperform | Downgrade | $N/A |
Ardent Health Partners Inc. (ARDT) Competitors
The following stocks are similar to Ardent Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ardent Health Partners Inc. (ARDT) Financial Data
Ardent Health Partners Inc. has a market capitalization of $1.24B with a P/E ratio of 9.1x. The company generates $6.43B in trailing twelve-month revenue with a 2.1% profit margin.
Revenue growth is +7.0% quarter-over-quarter, while maintaining an operating margin of +5.1% and return on equity of +13.9%.
Valuation Metrics
Market Cap
$1.24B
Enterprise Value
$3.32B
P/E Ratio
9.1x
PEG Ratio
-1.4x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
+7.0%
Gross Margin
+41.9%
Operating Margin
+5.1%
Net Margin
+2.1%
EPS Growth
-3.7%
Financial Health
Cash/Price Ratio
+48.3%
Current Ratio
2.1x
Debt/Equity
132.3x
ROE
+13.9%
ROA
+4.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Ardent Health Partners Inc. (ARDT) Business Model
About Ardent Health Partners Inc.
What They Do
Provider of healthcare services in urban communities.
Business Model
The company operates a network of 30 acute care hospitals and approximately 280 additional care sites, including clinics and emergency departments, generating revenue through a diverse range of medical services. Its consumer-centric approach integrates technology and patient-focused care to build long-lasting relationships, enhancing service delivery and patient satisfaction, which in turn drives financial performance.
Additional Information
Ardent Health serves around 15,000 patients daily and has over 2,000 affiliated providers. The company went public in July 2024 and rebranded in June 2025, maintaining its NYSE ticker symbol ARDT.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
19,500
CEO
Mr. Martin J. Bonick FACHE, M.H.A.
Country
United States
IPO Year
2024
Website
www.ardenthealth.comArdent Health Partners Inc. (ARDT) Latest News & Analysis
Latest News
Ardent Health Appoints Dave Caspers as CEO
6 days ago
Quick Summary
Ardent Health has appointed Dave Caspers as President and CEO, effective immediately, succeeding Marty Bonick, who has left the company for other opportunities.
Why It Matters
Leadership changes can impact company strategy and performance. Investors may reassess Ardent Health's growth prospects and operational direction under the new CEO, affecting stock valuation.
Source: Business Wire
Market Sentiment:
Neutral
Ardent Health to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
5 days ago
Quick Summary
Ardent Health (NYSE: ARDT) will participate in the Goldman Sachs Global Healthcare Conference on June 10, 2026, at 11:20 a.m. ET. A live webcast will be available for investors.
Why It Matters
Ardent Health's participation in a major healthcare conference highlights its visibility and potential growth, signaling to investors a commitment to engaging with the market and stakeholders.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Ardent Health (NYSE: ARDT) has partnered with FUJIFILM Healthcare to implement Synapse® enterprise imaging solutions across its hospitals in six states, enhancing patient imaging data access for clinicians.
Why It Matters
Ardent Health's partnership with FUJIFILM enhances its imaging capabilities, potentially improving patient care and operational efficiency, which can drive revenue growth and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Ardent Health, Inc. (ARDT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
26 days ago
Quick Summary
Ardent Health, Inc. (ARDT) presented at the Bank of America Global Healthcare Conference, providing insights into its operations and future outlook.
Why It Matters
Ardent Health's presentation at a major healthcare conference signals potential growth opportunities and strategic insights, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Ardent Health, Inc. (ARDT) held its Q1 2026 earnings call, providing insights into the company's financial performance and operational updates for the quarter.
Why It Matters
Ardent Health's Q1 2026 earnings call provides insights into financial performance, operational strategies, and market conditions, influencing stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Ardent Health Reports First Quarter 2026 Results
1 month ago
Quick Summary
Ardent Health, Inc. (NYSE: ARDT) reported its financial results for Q1 2026, comparing metrics to the same period last year. Further details are available in the accompanying press release.
Why It Matters
Ardent Health's Q1 2026 results indicate financial performance trends that could impact stock valuation and investor sentiment in the healthcare sector.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About ARDT Stock
What is Ardent Health Partners Inc.'s (ARDT) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Ardent Health Partners Inc. (ARDT) has a median price target of $13.00. The highest price target is $14.00 and the lowest is $10.00.
Is ARDT stock a good investment in 2026?
According to current analyst ratings, ARDT has 7 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $8.83. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ARDT stock?
Wall Street analysts predict ARDT stock could reach $13.00 in the next 12 months. This represents a 47.2% increase from the current price of $8.83. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Ardent Health Partners Inc.'s business model?
The company operates a network of 30 acute care hospitals and approximately 280 additional care sites, including clinics and emergency departments, generating revenue through a diverse range of medical services. Its consumer-centric approach integrates technology and patient-focused care to build long-lasting relationships, enhancing service delivery and patient satisfaction, which in turn drives financial performance.
What is the highest forecasted price for ARDT Ardent Health Partners Inc.?
The highest price target for ARDT is $14.00 from at , which represents a 58.6% increase from the current price of $8.83.
What is the lowest forecasted price for ARDT Ardent Health Partners Inc.?
The lowest price target for ARDT is $10.00 from at , which represents a 13.3% increase from the current price of $8.83.
What is the overall ARDT consensus from analysts for Ardent Health Partners Inc.?
The overall analyst consensus for ARDT is bullish. Out of 2 Wall Street analysts, 7 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $13.00.
How accurate are ARDT stock price projections?
Stock price projections, including those for Ardent Health Partners Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 2:08 AM UTC